iBio Announces Pricing of $50 Million Public Offering
I'm PortAI, I can summarize articles.
SAN DIEGO, Aug. 19, 2025 ( GLOBE NEWSWIRE ) -- iBio, Inc. ( Nasdaq: IBIO ) , an AI-driven innovator of precision antibody therapies, today announced the pricing of an underwritten public offering ( the "offering" ) of ( i ) pre-funded warrants to purchase 71,540,000 shares of iBio's common stock ...
Source: GlobeNewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments